APYX vs SCHW · rev $26.4M vs P/E 19, rev $23.92B
Apyx Medical Inc (APYX) versus Charles Schwab Corp (SCHW) — a side-by-side from cached financials, not a winner call.
Apyx Medical Inc (APYX) is a medical devices company listed on US.
Charles Schwab Corp (SCHW) is a capital markets company listed on NYSE. It is led by Walt Bettinger.
Latest reported APYX revenue for 2026-06-30 was $26.4M. Net income was -$5.4M. APYX currently screens at market cap $179.6M.
Latest reported SCHW revenue for 2025-12-31 was $23.92B. Net income was $8.85B. Revenue was up 22.0% from 2024-12-31 to 2025-12-31. SCHW currently screens at market cap $164.37B and trailing P/E 18.8.
APYX currently screens at market cap $179.6M. SCHW currently screens at market cap $164.37B and trailing P/E 18.8.
Not investment advice. Open the APYX and SCHW stock pages for the full models.
Not investment advice.